Inventor · disambiguated record
Yangsheng Qiu
Also filed as: QIU YANGSHENG
5 granted patents·7 pending applications·12 citations·filing 2016–2022
69Inventor score
Files withELPISCIENCE SUZHOU BIOPHARMA LTD7GLAXOSMITHKLINE IP DEV LTD3UNIV SHANGHAI JIAOTONG1ZLIP HOLDING LTD1
Top patents by PatentIndex Score
12 records- 0189US9914781B1Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 13, 2018·10 cites·6 claims
- 0264US11267885B2CD47 antigen binding unit and uses thereofZLIP HOLDING LTD·Filed 2018·Granted Mar 8, 2022·2 cites·21 claims
- 0360US2021347902A1Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0448US11078287B2Binding agonist for treatment of neurological and other disordersGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 3, 2021·0 cites·18 claims
- 0548US2025313625A1Novel anti-lag3 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 0648US2025270315A1Novel anti-sirpa antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 0748US2024336686A1Novel multi-specific moleculesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 0843US10995142B2Monoclonal antibody FnAb8 and application thereofUNIV SHANGHAI JIAOTONG·Filed 2017·Granted May 4, 2021·0 cites·15 claims
- 0942US2023416394A1Novel conjugate molecules targeting cd39 and tgfbetaELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 1040US2024270839A1Novel anti-claudin18 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 1138US2021347908A1Novel anti-sirpa antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 1237US12312410B2Anti-CD39 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2020·Granted May 27, 2025·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Yangsheng Qiu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →